New joint venture to commercialise cancer drug toripalimab in 9 Southeast Asian countries

Shanghai Junshi Biosciences Co. and Rxilient Biotech have announced a collaboration on the development an...

March 30, 2023 | Thursday | News
Korea's HanAll Biopharma assigns Su-jin Park as Co-CEO to drive next growth phase

South Korea-based HanAll Biopharma has announced that Su-jin Park has been appointed as new Co-Chief Executive Officer (...

March 30, 2023 | Thursday | News
Japan's Kaken Pharma inks drug discovery collaboration with bitBiome for infectious diseases

Japanese startup bitBiome, Inc. and Kaken Pharmaceuticals have signed a joint research agreement on the discovery o...

March 30, 2023 | Thursday | News
Potential for new pharma packaging and labeling technologies in APAC

The importance of proper labeling and packaging for pharmaceutical and healthcare products cannot be understated. Pharma...

March 29, 2023 | Wednesday | Opinion
Two Australian healthcare companies to develop radiopharmaceutical treatments for cancer

Radiopharm Theranostics, a clinical-stage radiotherapeutics company, and GenesisCare, a leading global provider of integ...

March 30, 2023 | Thursday | News
Fujitsu launches new cloud-based platform for healthcare sector in Japan

Fujitsu has announced the launch of a new cloud-based platform that allows users to securely collect and leverage health...

March 28, 2023 | Tuesday | News
Revolutionising Drug Development with focus on label-free technologies amid US FDA legislation

The new FDA Modernization Act 2.0 has recently been signed by US president Biden, resulting in the revocation of the lon...

March 27, 2023 | Monday | Opinion
Bayer allocates resources to grow oncology and cardiology biz in US

During this year’s Pharma Media Day 2023 on March 24th, German pharmaceutical firm Bayer showcased how its investm...

March 25, 2023 | Saturday | News
Everest Medicines partners with Guangdong Academy of Medical Sciences for renal diseases research

China-based startup Everest Medicines, has signed a Memorandum of Understanding (MoU) for comprehensive strategic cooper...

March 24, 2023 | Friday | News
German firm Brenntag opens first Pharmaceutical Application Development Centre in Singapore

Brenntag, the global market leader in chemicals and ingredients distribution based in Germany, has announced the opening...

March 24, 2023 | Friday | News
Taiwan's TaiGen Biotech takes pan-influenza antiviral drug to China

Taiwan's TaiGen Biotechnology has signed an exclusive licensing agreement with Joincare Pharmaceutical Group, a Chinese ...

March 22, 2023 | Wednesday | News
CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders

The 20th anniversary edition of the CPHI Pharma Awards is now open for entries, with three new categories created t...

March 21, 2023 | Tuesday | News
World's first study to prove myopia prevention in children by low-concentration atropine drops

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...

March 14, 2023 | Tuesday | News
GHIT Fund invests ¥ 260 M for new malaria drug development by Japanese firms

The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 2...

March 13, 2023 | Monday | News
Elevating Life science industry standards through the implementation of quality practices

Lifescience Laboratory workflows, products and services are complex and can be difficult to manage due to long and strin...

March 10, 2023 | Friday | Analysis
Australia's Starpharma names Justin Cahill as Chief Financial Officer and Company secretary

Australian firm Starpharma Holdings has announced the appointment of Justin Cahill as Chief Financial Officer (CFO)...

March 10, 2023 | Friday | News
Japanese firm Sumitomo invests in radiopharmaceutical startup Alpha Fusion

Japan-based Sumitomo Heavy Industries (SHI) has announced the decision to invest in Alpha Fusion Inc. (AF), a developer ...

March 9, 2023 | Thursday | News
China's Biocytogen partners with Janssen for discovery of new antibody-based drugs

China-based Biocytogen Pharmaceuticals has announced the signing of a non-exclusive license agreement with Janssen Biote...

March 9, 2023 | Thursday | News
Japan's Teijin Pharma inks $230 M deal with Novartis for kidney diseases treatment

Teijin Pharma, based in Japan, has entered into an exclusive global license agreement with Swiss firm Novartis t...

March 8, 2023 | Wednesday | News
Kyorin and Sumitomo to introduce drug for overactive bladder in Taiwan & other Asian countries

Kyorin Pharmaceutical, a subsidiary of Kyorin Holdings, Inc. and Sumitomo Pharma, in Japan, have entered into a license ...

March 7, 2023 | Tuesday | News
The New Pandemic of Layoffs

The word layoff is accustomed to us and many companies across the globe take part in this exercise. Excuses like global ...

March 6, 2023 | Monday | Analysis
Biogen terminates multiple sclerosis (MS) pact with Eisai in Japan

Biogen Japan and Eisai have announced the termination of the co-promotion agreement that has been in place since January...

March 3, 2023 | Friday | News
CPHI & PMEC China 2023 to attract over 55,000 visitors on 19-21 June

In 2023, CPHI & PMEC China will be held in 19-21 June 2023 at SNIEC (Shanghai New International Expo Centre), Shangh...

March 2, 2023 | Thursday | News
Deprecated Yen attracts renewed international interest in Japanese pharma

CPHI Japan 2023 opens in April (19-21) as the country undergoes a huge resurgence in international trade, with West...

March 1, 2023 | Wednesday | News
Korea's GC Biopharma buys rare disease pipeline in haematology from Catalyst Biosciences

GC Biopharma, a leading provider of biopharmaceutical products in South Korea, has signed an Asset Purchase Agreement wi...

February 28, 2023 | Tuesday | News